CClinicalTrials.gg
CompletedNCT05678725Updated May 10, 2024

Transcranial Direct/ Alternating Current Stimulation for Parkinson's Disease Treatment

An interventional study of tACS and tDCS in tACS and tDCS, sponsored by Anhui Medical University. Completed at 1 site in China. Open to participants aged 40 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-05-10.

Sponsored by Anhui Medical University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
40 Years to 80 Years
Sex
All
01

Study summary

To investigate the difference in the treatment efficacy between transcranial direct current stimulation and transcranial alternating current stimulation on Parkinson's disease, including the improvements in the motor, cognitive, and underlying neural mechanisms behind differences in efficacy by electroencephalography (EEG).

Read the detailed description

All patients underwent a medical evaluation that include physical examinations and routine laboratory studies before and after stimulation sessions. Patients were randomly allocated to tACS, tDCS, and sham groups. There are about 20 patients in each group. Allocation was by computer generating random numbers. The decision to enroll a patient was always made prior to randomization. Patients were studied using a double-blind design. Study participants, clinical raters, and all personnel responsible for the clinical care of the patient remained masked to allocated conditions and allocation parameters. Only stimulation administrators had access to the randomization list; they had minimal contact with the patients, and no role in assessing the UPDRS(Unified Parkinson´s Disease Rating Scale), Hoehn \& Yahr, and MoCA(Montreal Cognitive Assessment). Each patient would be treated for 20 minutes of transcranial electrical stimulation.

Before the stimulation session, UPDRS, Hoehn \& Yahr, and MoCA were obtained by a trained investigator to assess the baseline severity of symptoms. The patients received electroencephalography (EEG) recorded during resting state for 5 minutes.

During the stimulation session, patients were asked to perform simple reaction tasks at the same time.

After the stimulation session, UPDRS, Hoehn \& Yahr, and MoCA were obtained, as well as the Global Index of Safety(tES side effects) to assess adverse events of the treatment. The patients also received a measure of electroencephalography (EEG) recorded during the resting state.

02

Conditions studied

  • tACS
  • tDCS

Browse trials for

03

In context

Parkinson Disease

4,487 studies on the registry are indexed under Parkinson Disease; 1,082 are open to participants now.

This study's enrollment of 60 is above the median of 40 across 3,294 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

Anhui Medical University is the lead sponsor of 102 studies on the registry; 50 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • diagnosis of idiopathic PD according to the movement disorder society criteria
  • right-handed
  • no clinically known hearing or vision impairment
  • no history of epilepsy, dementia, other brain disorders apart from PD, severe internal organs disease, age-related frailty, etc.

Exclusion criteria

Exclusion Criteria:

  • parkinsonism due to drugs, Cerebrovascular disease, encephalitis, poisoning, traumatic brain injury, etc.
  • Metal implants in the head (i.e., deep brain stimulator or aneurysm clips)
  • severe somatic or psychiatric disorders that require medication or routinely monitoring
  • participated in other interventional studies within the past 3 months
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Active comparator
    Transcranial Alternating Current Stimulation

    the alternating current stimulation lasted 20 mins and was delivered at 2mA (peak to peak) at 20Hz during the Simple Reaction Task(SRT), targeting the primary motor cortex. EEG should be acquired before and after the stimulation session.

    Device: tACS

  • Active comparator
    Transcranial Direct Current Stimulation

    the direct current stimulation lasted 20 minutes and was delivered at 2mA during the SRT, targeting at the primary motor cortex. EEG should be acquired before and after the stimulation session.

    Device: tDCS

  • Sham comparator
    Sham Group with No Actual Stimulation

    the procedure of this protocol lasted 20 minutes and was delivered at 0mA during the SRT. EEG should be acquired before and after the stimulation session.

    Device: sham

Interventions

  • DevicetACS

    used round electrodes(area:3.14cm2) and the montage of a bifrontal setup with C3 as the stimulation electrode, while the return electrode placed on the right shoulder . The dose was at 2mA, 20Hz for 20 minutes.

  • DevicetDCS

    used round electrodes(area:3.14cm2) and the montage of a bifrontal setup with C3 as stimulation and C4 as return electrodes. The dose was at 2mA for 20 minutes.

  • Devicesham

    used round electrodes(area:3.14cm2) and the montage of a bifrontal setup with C3 as stimulation and C4 as return electrodes. The stimulation lasted for 20 minutes and included a 10-second ramp-up and 10-second ramp-down.

06

What researchers measure

Primary outcomes

  1. the changes in UPDRS III

    Unified Parkinson´s Disease Rating Scale Section III-motor is the sum of 18 items, each item contains 0-4 ratings, where 0=normal, 1= slight, 2= mild, 3=moderate, 4=severe.

    Time frame: pre-stimulation; post-stimulation (immediate after stimulation)

  2. the changes in EEG power

    EEG recording by 8 channels EEG device.

    Time frame: pre-stimulation; post-stimulation (immediate after stimulation)

Secondary outcomes

  1. simple reaction task

    First , there was a fixation sign"+" appearing on the screen for 0.5 s, then, after 2-5 seconds, a black dot would appear. Participants were instructed to press the space bar as fast as possible when the black dot appears in the center of the screen, to measure simple perception and sustained alertness. The changes in accuracy(ACC), reaction time(RT), and ACC/RT were calculated.

    Time frame: pre-stimulation; post-stimulation (immediately after stimulation)

  2. the changes in MoCA

    Montreal Cognitive Assessment is a 30-question test to assess cognitive function.

    Time frame: pre-stimulation; post-stimulation (immediately after stimulation)

07

Study locations

1 site
  • Anhui Medical University
    Hefei, Anhui 230032, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 10, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05678725
Lead sponsor
Anhui Medical University
Responsible party
Junjie Bu (Associate Professor, Anhui Medical University) — Principal investigator
First posted
Jan 10, 2023
Start date
Feb 15, 2023
Primary completion
Jan 15, 2024
Completion
Feb 15, 2024
Last update
May 10, 2024

Study contacts

Junjie Bu, Professor
study chair · Anhui Medical University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion